Case report of a transfusion-associated hepatitis A infection

Transfusion

Volumn 54, Issue 9, 2014, Pages 2202-2206

  Hughes, Jonathan A ^a   Fontaine, Magali J ^a   Gonzalez, Christopher L ^a,b   Layon, Arlene G ^a,b   Goodnough, Lawrence Tim ^a   Galel, Susan A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford Medicine Children s Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOMEGALOVIRUS ANTIBODY; FRESH FROZEN PLASMA; HEPATITIS A VACCINE; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN M;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD DONOR; CASE REPORT; ERYTHROCYTE; FATIGUE; FEMALE; GASTROESOPHAGEAL REFLUX; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INFANT; POLYMERASE CHAIN REACTION; POSTTRANSFUSION HEPATITIS; TRANSFUSION ASSOCIATED HEPATITIS A; TREATMENT OUTCOME; VACCINATION; VIREMIA; ADOLESCENT; BLOOD TRANSFUSION; IMMUNOLOGY; MALE; MIDDLE AGED; TRANSMISSION;

ADOLESCENT; BLOOD TRANSFUSION; FEMALE; HEPATITIS A; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED;

EID: 84908153741     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12648     Document Type: Article

References (34)

1. American Association of Blood Banks. Emerging infectious disease agents and their potential threat to transfusion safety. 2013 [cited 2014 Mar 17]. Available from: http://www.aabb.org/resources/bct/eid/Pages/default.aspx
2. Noble RC, Kane MA, Reeves SA, et al. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 1984; 252:2711-5.
3. Hollinger FB, Khan NC, Oefinger PE, et al. Posttransfusion hepatitis type A. JAMA 1983;250:2313-7.
4. Seeberg S, Brandberg A, Hermodsson S, et al. Hospital outbreak of hepatitis A secondary to blood exchange in a baby. Lancet 1981;1:1155-6.
5. Barbara JA, Howell DR, Briggs M, et al. Post-transfusion hepatitis A. Lancet 1982;1:738.
6. Diwan AH, Stubbs JR, Carnahan GE. Transmission of hepatitis A via WBC-reduced RBCs and FFP from a single donation. Transfusion 2003;43:536-40.
7. American Academy of Pediatrics. Hepatitis A. In: Pickering LK, editor. 29th ed. Red book: 2012 report of the committee on infectious diseases. Elk Grove Village (IL): American Academy of Pediatrics; 2012. p. 361-9.
8. Sherertz RJ, Russell BA, Reuman PD. Transmission of hepatitis A by transfusion of blood products. Arch Intern Med 1984;144:1579-80.
9. Azimi PH, Roberto RR, Guralnik J, et al. Transfusionacquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery. Am J Dis Child 1986;140:23-7.
10. Giacoia GP, Kasprisin DO. Transfusion-acquired hepatitis A. South Med J 1989;82:1357-60.
11. Nigro G, Del Grosso B. Transfusion acquired hepatitis A in a patient with B thalassaemia major. J Infect 1990;20:175-6.
12. Lee KK, Vargo LR, Le CT, et al. Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit. Pediatr Infect Dis J 1992;11:122-3.
13. Gowland P, Fontana S, Niederhauser C, et al. Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus. Transfusion 2004;44:1555-61.
14. Vermylen J, Peerlinck K. Review of the hepatitis A epidemics in hemophiliacs in Europe. Vox Sang 1994;67(Suppl 4):8-11; discussion 24-6.
15. Soucie JM, Robertson BH, Bell BP, et al. Hepatitis A virus infections associated with clotting factor concentrate in the United States. Transfusion 1998;38:573-9.
16. Hollinger BF, Emerson SU. Hepatitis A virus. In: Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia (PA): LippincottWilliams &Wilkins; 2006. p. 911-46.
17. Pringle CR. The universal system of virus taxonomy of the International Committee on Virus Taxonomy (ICTV), including new proposals ratified since publication of the Sixth ICTV Report in 1995. Arch Virol 1998;143:203-10.
18. Purcell RH, Feinstone SM, Ticehurst JR, et al. Hepatitis A virus. In: Vyas GN, Dienstag JL, Hoofnagle JH, editors. Viral hepatitis and liver disease. Orlando (FL): Grune & Stratton; 1984. p. 9-22.
19. Bower WA, Nainan OV, Han X, et al. Duration of viremia in hepatitis A virus infection. J Infect Dis 2000;182:12-7.
20. Hadler SC, Webster HM, Erben JJ, et al. Hepatitis A in daycare centers. A community-wide assessment. N Engl J Med 1980;302:1222-7.
21. Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985;122:226-33.
22. Lemon SM. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem 1997;43:1494-9.
23. Koff RS. Hepatitis A. Lancet 1998;351:1643-9.
24. Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis 2004;38:705-15.
25. Centers for Disease Control and Prevention. Surveillance for viral hepatitis-United States, 2011. Atlanta (GA): CDC; 2013. [cited 2014 Mar 17]. Available from: http://www.cdc.gov/hepatitis/Statistics/2011Surveillance/index.htm
26. Sharapov UM, Teshale EH. Hepatitis A. In: Brunette GW, editor. Health information for international travel. Atlanta (GA): CDC; 2013. p. 182-6. [cited 2014 Mar 17]. Available from http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/hepatitis-ap
27. Carson TH, editor. Standards for blood banks and transfusion services. 28th ed. Bethesda (MD): American Association of Blood Banks; 2012.
28. Food and Drug Administration. Guidance for industry: assessing donor suitability and blood and blood product safety in cases of known or suspectedWest Nile virus infection. (June 2005) Rockville, MD: CBER Office of Communication, Outreach, and Development, 2005. [cited 2014 Mar 17]. Available from: http://www.fda.gov/BiologicsBlood Vaccines/GuidanceComplianceRegulatoryInformation/ Guidances/Blood/ucm074111.htm
29. Weimer T, Streichert S, Watson C, et al. Hepatitis A virus prevalence in plasma donations. J Med Virol 2002;67:469-71.
30. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States, 2000. MMWR Morb Mortal Wkly Rep 2000;49:1-102.
31. Jones S, Leighton K, Chapa J, et al. Prevalence of hepatitis A virus (HAV) and high titer parvovirus B19 in recovered and source plasma donations. Transfusion 2013;53(Suppl 2):211A.
32. Jones S, Leighton K, Chapa J, et al. Development of a molecular beacon NAT assay for hepatitis A virus. Transfusion 2009;49(Suppl 3):219A.
33. Berge JJ, Drennan DP, Jacobs RJ, et al. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 2000;31:469-73.
34. Luyten J, Beutels P. Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A. Pharmacoeconomics 2009;27:379-89.